XML 58 R18.htm IDEA: XBRL DOCUMENT
v3.24.0.1

Incentive Plans | 12 Months Ended
--- | ---
Dec. 31, 2023
Share-Based Payment Arrangement [Abstract] |
Incentive Plans | Note I – Incentive Plans Murphy utilizes cash-based and/or share-based incentive awards to supplement normal salaries as compensation for executive management and certain employees. For share-based awards that qualify for equity accounting, costs are recognized as an expense in the Consolidated Statements of Operations, using a grant date fair value-based measurement method, over the periods that the awards vest. For cash-settled equity awards that are required to be accounted for under liability accounting rules, costs are recognized as expense using a fair value-based measurement method over the vesting period, but expense is adjusted as necessary through the date the award value is finally determined. Total expense for liability awards is ultimately adjusted to the final intrinsic value for the award. The Company currently has outstanding incentive awards issued to certain employees under the Annual Incentive Plan (AIP), the 2012 Long-Term Incentive Plan (2012 Long-Term Plan), the 2018 Long-Term Incentive Plan (2018 Long-Term Plan) and the 2020 Long-Term Incentive Plan (2020 Long-Term Plan). The AIP authorizes the Compensation Committee (the Committee) to establish specific performance goals associated with annual cash awards that may be earned by officers, executives and certain other employees. Cash awards under the AIP are determined based on the Company’s actual financial and operating results as measured against the performance goals established by the Committee. The 2020 Long-Term Plan authorizes the Committee to make grants of the Company’s common stock to employees. These grants may be in the form of stock options (nonqualified or incentive), SARs, restricted stock, restricted stock units (RSUs), performance units, performance shares, dividend equivalents and other stock-based incentives. The 2020 Long-Term Plan expires in 2030. A total of 5 million shares are issuable during the life of the 2020 Long-Term Plan. Shares issued pursuant to awards granted under this Plan may be shares that are authorized and unissued or shares that were reacquired by the Company, including shares purchased in the open market. Share awards that have been canceled, expired, forfeited or otherwise not issued under an award shall not count as shares issued under this Plan. Based on awards made to date, 2.1 million shares are available for grant under the 2020 Long-Term Plan at December 31, 2023. The Stock Plan for Non-Employee Directors (2021 NED Plan) permits the issuance of restricted stock, restricted stock units and stock options or a combination thereof to the Company’s Non-Employee Directors. The Company currently has outstanding incentive awards issued to Directors under the 2021 NED Plan and the 2018 Stock Plan for Non-Employee Directors (2018 NED Plan). The Company generally expects to issue treasury shares to satisfy vesting of restricted stock and restricted stock units. Amounts recognized in the financial statements with respect to share-based plans for each of the three years presented are shown in the following table.
(Thousands of dollars) | 2023 |  | 2022 |  | 2021
Compensation charged against income before income tax benefit | $ | 58,760 |  |  | $ | 74,587 |  |  | $ | 43,660 |
Related income tax benefit recognized in income | 9,330 |  |  | 12,710 |  |  | 7,196 |
As of December 31, 2023, there were $47.4 million in compensation costs, to be expensed over approximately the next three years, related to unvested share-based compensation arrangements granted by the Company. Employees receive net shares, after applicable withholding obligations, upon each stock option exercise and restricted stock unit vest. Equity-Settled Awards PERFORMANCE-BASED RESTRICTED STOCK UNITS – PSUs to be settled in common shares were granted in 2020 under the 2018 Long-Term Plan, and in 2021, 2022 and 2023 under the 2020 Long-Term Plan. Each grant will vest if the Company achieves specific performance objectives at the end of the designated performance period. Additional shares may be awarded if performance objectives are exceeded. If performance goals are not met, PSUs will not vest, but the recognized compensation cost associated with the stock award would not be reversed. For PSUs, the performance conditions are based on the Company’s total shareholder return (80% weighting), compared to an industry peer group of companies, and the EBITDA divided by Average Capital Employed metric (20% weighting) for PSU awards, over the performance period. During the performance period, PSUs are subject to transfer restrictions and are subject to forfeiture if a grantee terminates for reasons other than retirement, disability or death. Termination for these three reasons will lead to a pro rata award of amounts earned. No dividends are paid nor do voting rights exist on awards of PSUs prior to their settlement. Changes in PSUs outstanding for each of the last three years are presented in the following table.
(Number of stock units) | 2023 |  | 2022 |  | 2021
Outstanding at beginning of year | 2,148,467 |  |  | 2,670,756 |  |  | 2,207,429 |
Granted | 409,160 |  |  | 595,700 |  |  | 1,156,800 |
Vested and issued | (408,135) |  |  | (654,177) |  |  | (642,473) |
Forfeited | (331,304) |  |  | (463,812) |  |  | (51,000) |
Outstanding at end of year | 1,818,188 |  |  | 2,148,467 |  |  | 2,670,756 |
The fair value of the equity-settled performance-based awards granted in each year was estimated on the date of grant using a Monte Carlo valuation model. Expected volatility was based on daily historical volatility of the Company’s stock price compared to a peer group average over a three-year period. The risk-free interest rate is based on the yield curve of three-year U.S. Treasury bonds, and the stock beta was calculated using three years of historical averages of daily stock data for Murphy and the peer group. The assumptions used in the valuation of the performance awards granted in 2023, 2022 and 2021 are presented in the following table.
| 2023 |  | 2022 |  | 2021
Fair value per share at grant date | $60.46 |  | $37.77 - $47.37 |  | $16.03
Assumptions |  |  |  |  |
Expected volatility | 81.00% |  | 79.00% - 81.00% |  | 74.00%
Risk-free interest rate | 3.90% |  | 1.39% -2.85% |  | 0.18%
Stock beta | 1.034 |  | 1.195 - 1.200 |  | 1.169
Expected life | 3.0 years |  | 3.0 years |  | 3.0 years
TIME-BASED RESTRICTED STOCK UNITS – Time-based RSUs have been granted to the Company’s Non-Employee Directors (NED) under the 2018 NED Plan and 2021 NED Plan, and to certain employees under the 2020 Long-Term Plan. The fair value of the time-based restricted stock units awarded for each of the last three years are presented in the following table.
Type of Plan | Valuation Methodology |  | 2023 |  |  | 2022 |  | 2021
Non-Employee Directors 1 | Closing Stock Price at Grant Date |  | $43.27 |  |  | $32.84 |  | $13.14 - $23.58
Long-Term Incentive Plan 2 | Average Low/High Stock Price at Grant Date |  | $42.20 |  |  | $29.80 - $49.86 |  | $12.30
1 Under the 2021 NED Plan, RSUs granted in 2023 are scheduled to vest in February 2024. 2 The RSUs granted under the 2018 and 2020 Long-Term Plan generally vest on the third anniversary of the date of grant. Changes in RSUs outstanding for each of the last three years are presented in the following table.
(Number of share units) | 2023 |  | 2022 |  | 2021
Outstanding at beginning of year | 1,227,792 |  |  | 1,451,438 |  |  | 1,383,043 |
Granted | 556,100 |  |  | 416,492 |  |  | 573,907 |
Vested and issued | (517,047) |  |  | (462,418) |  |  | (476,012) |
Forfeited | (47,261) |  |  | (177,720) |  |  | (29,500) |
Outstanding at end of year | 1,219,584 |  |  | 1,227,792 |  |  | 1,451,438 |
STOCK OPTIONS – In 2017, the Company ceased the inclusion of stock options and SARs as a part of the long-term incentive compensation mix. Prior to 2017, the Committee fixed the option price of each option granted at no less than fair market value (FMV) on the date of the grant and fixed the option term at no more than seven years from such date. Each option granted to date under the 2012 Long-Term Plan has been nonqualified, with a term of seven years and an option price equal to FMV at date of grant. Under these plans, one-half of each grant is generally exercisable after two years and the remainder after three years. For stock options, the number of shares issued upon exercise is reduced for settlement of applicable statutory income tax withholdings owed by the grantee. The fair value of each option award was estimated on the date of grant using the Black-Scholes pricing model based on the assumptions noted in the following table. Expected volatility is based on historical volatility of the Company’s stock and implied volatility on publicly traded at-the-money options on the Company’s stock. The Company estimates the expected term of the options granted based on historical option exercise patterns and considers certain groups of employees exhibiting different behavior. The risk-free interest rate for periods within the expected term of the option is based on the U.S. Treasury yield curve in effect at the time of grant. Changes in stock options outstanding during the last three years are presented in the following table.
| Number of Shares |  | Average Exercise Price
Outstanding at December 31, 2020 | 2,048,400 |  |  | 40.14 |
Exercised | (170,000) |  |  | 17.57
Forfeited | (558,900) |  |  | 52.61
Outstanding at December 31, 2021 | 1,319,500 |  |  | 37.77
Exercised | (760,500) |  |  | 23.29
Forfeited | (546,000) |  |  | 49.65
Outstanding at December 31, 2022 | 13,000 |  |  | 28.51
Exercised | (11,000) |  |  | 28.51
Forfeited | (2,000) |  |  | 28.51
Outstanding at December 31, 2023 | – |  |  | –
Exercisable at December 31, 2020 | 2,048,400 |  |  | 37.88 |
Exercisable at December 31, 2021 | 1,319,500 |  |  | 34.25 |
Exercisable at December 31, 2022 | 13,000 |  |  | 28.51 |
Exercisable at December 31, 2023 | – |  |  | –
The total intrinsic value of options exercised during 2023 was $0.16 million. Intrinsic value is the excess of the market price of stock at date of exercise over the exercise price received by the Company upon exercise. Aggregate intrinsic value is nil when the exercise price of the stock option exceeds the market price of the Company’s common stock. Cash-Settled Awards The Company has granted phantom stock-based incentive awards to be settled in cash to certain employees in the form of SARs and CRSUs. SAR awards have terms similar to stock options. CRSUs generally settle on the third anniversary of the date of grant. Each award granted is settled, net of applicable income tax withholdings, in cash rather than with common shares. Total pre-tax expense recorded in the Consolidated Statements of Operations for all cash-settled stock-based awards was $29.4 million in 2023, $49.3 million in 2022 and $18.2 million in 2021. The Committee also administers the Company’s incentive compensation plans, which provide for annual or periodic cash awards to officers, directors and certain other employees. These cash awards are generally determinable based on the Company achieving specific financial and/or operational objectives. Compensation expense of $30.9 million, $42.9 million and $29.0 million was recorded in 2023, 2022 and 2021, respectively, for these plans.

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//718/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (h)(2)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (l) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration